IGF2BP2 and neoplasm: DEN is either given as a single dose by itself or in combination with the tumor-promoting agent phenobarbital to induce tumors with β-catenin mutations, which are linked to GS positivity.20 Interestingly, employing p62 transgenic mice, we observed GS-positive tumors in the DEN model without using phenobarbital.